OcuMedic, Inc. is the developer of the world's first drug-eluting therapeutic lens/clear corneal bandage for the delivery of drugs for the global ophthalmic market. Invented by Mark Byrne, Ph.D., distinguished engineering professor and Founding Head of the Department of Biomedical Engineering at Rowan University, the therapeutic lens is a soft contact developed in the most widely used safe lens material that precisely controls the release of a "first line" anti-inflammatory drug that targets post-operative eye care to reduce healing time and costly complications. The device is a platform technology, with OcuMedic demonstrating controlled release of a number of therapeutics for the duration of wear, targeted at the large and growing surgery, dry eye, corneal abrasion, and glaucoma markets.
| Website | http://ocumedic.us |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2006 |
| Address | 107 Gilbreth Pkwy, Mullica Hill, New Jersey 08062, US |
| Phone | +1 404-444-6030 |
| Industry | Biotechnology, Drug Delivery, Science and Engineering, Other Devices and Supplies, Medical, Health Care |
| Competitors | Novartis, Abbott, Optum, Alcon, ZEISS Group, Bausch + Lomb, Iridex, EyePoint Pharmaceuticals, Aerie Pharmaceuticals, Hoya Vision Care +24 more (view full list) |
Looking for a particular OcuMedic, Inc. employee's phone or email?
The OcuMedic, Inc. annual revenue was $5 million in 2026.
OcuMedic, Inc. is based in Mullica Hill, New Jersey.